AGTC News and Press, Applied Genetic Technologies Corporation From 02/05/20

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announce...

Applied Genetic Technologies Corporation (NASDAQ: AGTC) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “On Tuesday we attended AGTC's R&D Day in New York. Management showcased in granular detail data from its XLRP and ACHM ...

Applied Genetic Technologies (NASDAQ: AGTC ) is 6.3% lower postmarket after filing to offer shares . More news on: Applied Genetic Technologies Corporation, Healthcare stocks news, Stocks on the move, Read more ...

Ocean Bio-Chem (NASDAQ: OBCI ) +80%  as its subsidiary Star brite announces registered EPA product kills the Coronavirus . More news on: Ocean Bio-Chem, Inc., Happiness Biotech Group Limited, Delphi Technologies PLC, Stocks on the move, , Read more ...

SAN DIEGO, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced preclinical results from the company’s gene therapy collaboration with Applied Genetic ...

Acadia Healthcare (NASDAQ: ACHC ) resumed with Equal Weight rating and $36 (11% upside) price target at Stephens. More news on: Acadia Healthcare Company, Inc., BioMarin Pharmaceutical Inc., Blueprint Medicines Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

Applied Genetic Technologies (NASDAQ: AGTC ) is up 3.8% postmarket following an initiation at Buy by Roth Capital. More news on: Applied Genetic Technologies Corporation, Healthcare stocks news, Stocks on the move, Read more ...

Sarepta Therapeutics ( SRPT ) fell victim to the FDA's whims as the stock tumbled more than 3 percent following the issues raised by the FDA against its drug candidate Vyondys 53 (golodirsen). The drug was earlier rejected by the FDA last year. However, given what we can only call "popular p...

Genprex (NASDAQ: GNPX )  -37%  on pricing $8M stock offering. More news on: Genprex, Inc., Applied Genetic Technologies Corporation, Tetraphase Pharmaceuticals, Inc., Stocks on the move, , Read more ...

Investors are underwhelmed with Applied Genetic Technologies' (NASDAQ: AGTC ) announcement of "encouraging six-month data" from 22 patients participating in Phase 1/2 studies of its AAV gene therapy in patients with achromatopsia (color blindness) due to mutations in the ACHM CNGB3 or A...